검색
VolitionRX Ltd
VNRX관심 목록에 추가
2.000USD
-0.150-6.82%
종가 05/15, 16:00（ET）시세는 15분 지연됩니다
16.66M시가총액
손실P/E TTM
자세한 내용은 VolitionRX Ltd 회사
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRX Ltd 정보
종목 코드 VNRX
회사 이름VolitionRX Ltd
상장일Feb 06, 2015
CEOButera (Salvatore Thomas)
직원 수85
유형Ordinary Share
회계 연도 종료Feb 06
주소1489 West Warm Springs Road
도시HENDERSON
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호89014
전화17024251561
웹사이트https://volition.com/
종목 코드 VNRX
상장일Feb 06, 2015
CEOButera (Salvatore Thomas)
VolitionRX Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
196.86K
+5.92%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.66K
+10.94%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
31.97K
+31.59%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
31.19K
-0.85%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
21.20K
+40.80%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
18.94K
+14.10%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
18.19K
-3.54%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
16.56K
-2.28%
Ms. Kim Nguyen
Ms. Kim Nguyen
Independent Director
Independent Director
16.19K
+61.15%
Mr. Rodney Gerard Rootsaert
Mr. Rodney Gerard Rootsaert
Corporate Secretary
Corporate Secretary
13.70K
-2.65%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
196.86K
+5.92%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.66K
+10.94%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
31.97K
+31.59%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
31.19K
-0.85%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
21.20K
+40.80%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
18.94K
+14.10%
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Cotterford Co., Ltd.
7.42%
Lagoda Investment Management, L.P.
7.09%
The Lind Partners, LLC
2.76%
Innes (Guy Archibald)
2.43%
Reynolds (Cameron John)
1.65%
기타
78.65%
주주
주주
비율
Cotterford Co., Ltd.
7.42%
Lagoda Investment Management, L.P.
7.09%
The Lind Partners, LLC
2.76%
Innes (Guy Archibald)
2.43%
Reynolds (Cameron John)
1.65%
기타
78.65%
주주 유형
주주
비율
Investment Advisor
11.58%
Corporation
8.04%
Individual Investor
7.07%
Investment Advisor/Hedge Fund
1.07%
Research Firm
0.17%
Hedge Fund
0.14%
Bank and Trust
0.03%
기타
71.89%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
66
1.13M
13.93%
-209.80K
2025Q4
58
26.12M
21.27%
+1.98M
2025Q3
57
23.92M
20.70%
+1.72M
2025Q2
78
41.39M
40.30%
+860.69K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cotterford Co., Ltd.
12.01M
8.73%
--
--
Feb 09, 2026
Lagoda Investment Management, L.P.
11.46M
8.34%
-1.02M
-8.20%
Dec 31, 2025
The Lind Partners, LLC
4.46M
3.25%
+4.46M
--
Feb 09, 2026
Innes (Guy Archibald)
3.94M
2.86%
+233.25K
+6.30%
Feb 26, 2026
Reynolds (Cameron John)
2.67M
1.94%
+292.42K
+12.28%
Feb 26, 2026
Concord International Inc.
1.01M
0.73%
--
--
Feb 09, 2026
Geode Capital Management, L.L.C.
963.99K
0.7%
+85.82K
+9.77%
Dec 31, 2025
Hughes (Terig)
639.35K
0.46%
+202.00K
+46.19%
Feb 26, 2026
Micallef (Jacob Vincent)
623.85K
0.45%
-5.31K
-0.84%
Mar 17, 2026
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Apr 17, 2026
Merger
20→1
날짜
배당락일
유형
비율
Apr 17, 2026
Merger
20→1
